Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Vomiting × Dronabinol × Clear all

Phase

Status

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Cancer Pain 2 Vomiting 1 Pain 1

Interventions

Dexamethasone 11 Palonosetron 9 casopitant 6 Ondansetron 6 Granisetron 6 Aprepitant 5 netupitant, palosentron drug combination 3 Duration of Therapy 2 netupitant 1 dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 alizapride 1 Tropisetron 1 Tablets 1 NDC80 protein, human 1 Metoclopramide 1 Injections, Intravenous 1 Exercise 1 Dronabinol 1 Docetaxel 1 Cyclophosphamide 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05272865 2023-02-01

Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

LaSanta S A S

Phase 1/2 Unknown

Cancer Pain, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡